Having a large clinical trial portfolio means giving patients treatment options often not available anywhere else, and years before they become the standard of care. To learn more about Karmanos Cancer Institute clinical trials or to see if a trial is right for you, please call 1-800-KARMANOS (1-800-527-6266) or request an appointment below
  • ASk Questions in GYnecologic Oncology (ASQ-GYO): A randomized controlled trial of a question prompt list communication intervention in outpatient gynecologic oncology clinics

    Cancer Categories
    • Gynecologic
    Karmanos Trial ID
    • 2023-102
    NCT ID
    • NCT06339827
    Age Group
    • Adult
    Scope
    • Local
    PhaseClick for Clinical Trial Phase DefinitionQuestions, please contact us
    • N/A
    Principal Investigator
    • Ira
      Winer, M.D., Ph.D., FACOG

      Oncology - Gynecologic, Oncology - Surgical View Profile

    Objective:

    Aim 1: To determine the effectiveness of the ASQ-GYO QPL at improving patient self-efficacy, distress, physician trust, and knowledge compared to usual care during new patient gynecologic oncology visits at KCI. All patients will be asked to complete the 20-question Perceived Efficacy in Patient-Physician Interactions (PEPPI) instrument, a one-question National Comprehensive Care Network (NCCN) Distress Thermometer, and a 5-question Likert-scale Trust in Physicians scale on both pre- and post-visit surveys. All patients will be asked 10 Likert-scale knowledge-based questions regarding their diagnosis and plan on the post-visit survey.

    • The primary endpoint of this trial will be change in pre- and post-visit survey self-efficacy scores as determined by the PEPPI instrument compared by trial group.
    • Secondary endpoints will include change in pre- and post-visit survey NCCN Distress Thermometer scores and Trust in Physicians scores as well as post-visit survey knowledge scores compared by trial group.

    Aim 2: To determine the acceptability of the ASQ-GYO QPL with new gynecologic oncology patients.

    • Among Intervention group participants we will ask 15 Likert-scale and dichotomous questions in the post-visit survey regarding patients’ feelings about and the acceptability of the ASQ-GYO QPL.
  • Locations

    Locations

    Karmanos Cancer Institute - Detroit Headquarters

    4100 John R
    Detroit, MI 48201
    Get Directions
    Phone: 800-527-6266

    Karmanos Cancer Institute at Weisberg Cancer Center - Farmington Hills

    31995 Northwestern Hwy
    Farmington Hills, MI 48334
    Get Directions
    Phone: 800-527-6266

    Wayne State University

    6135 Woodward Avenue
    Detroit, MI 48202
    Get Directions